Last reviewed · How we verify
NCT07056738
Prospective Exploratory Cohort Study on Ganglion Cell Degeneration in Retinitis Pigmentosa Patients
trial testing imaging in Retinitis Pigmentosa in 130 participants. Enrolling by invitation.
1 March 2030
Quick facts
| Lead sponsor | University Medical Center Goettingen |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 130 |
| Start date | 1 March 2025 |
| Primary completion | 1 March 2030 |
| Estimated completion | 1 April 2030 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- imaging
Conditions studied
- Retinitis Pigmentosa — all drugs for Retinitis Pigmentosa →
Sponsor
University Medical Center Goettingen
Who can join
18 and older, any sex, with Retinitis Pigmentosa. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is an explorative prospective observation of retinal ganglion cell degeneration and/or inner retina degeneration in Retinitis pigmentosa patients. The rate and patterns of progression will be correlated to the outer retina layers as well as clinical and genetic data of patients. Secondary goal is to determine potential parameters for optogenetic treatment eligibility.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07056738
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of imaging
Trials testing the same drug.
- NCT06718608 — Natural Evolution of Muscle Structure and Stiffness Following Brain Lesion · NA · not yet recruiting
- NCT06286267 — AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors · recruiting
- NCT04976998 — Role of Ultrasonography in the Diagnosis of Carpal Tunnel Syndrome · unknown
- NCT05902650 — Correlation of Biochemical Indexes and Retinal Hemodynamic in Patients With Different Degrees of Diabetic Retinopathy · unknown
- NCT04360616 — The Diagnosis and Prognosis of Nonpalpable Breast Cancer Detected by the US vs Mammography: a Clinical Noninferiority Tr · unknown
Other recruiting trials for Retinitis Pigmentosa
Currently open trials in the same condition.
- NCT06891885 — A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years · Phase 1, PHASE2 · recruiting
- NCT07408232 — A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP) · Phase 1, PHASE2 · recruiting
- NCT07228793 — Natural History Study of Patients With EYS-Associated RP · recruiting
- NCT06319872 — The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration · Phase 1 · recruiting
- NCT06936787 — An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa · Phase 1 · recruiting
Other University Medical Center Goettingen trials
Trials by the same sponsor.
- NCT07505498 — Screening for Supportive Care Needs of Oncological Patients and Professionals - Evaluation of a Short PRO-question Set · recruiting
- NCT07008677 — Oral Health Awareness and Status Among Professional Musicians in German Orchestras · completed
- NCT07529041 — Real-time Acoustic Biofeedback for Enhancing Fixation Stability: A Proof-of-concept Study to Improve Ophthalmic Imaging · NA · enrolling by invitation
- NCT06921863 — This Study Aims to Quantify Decisional Regret as Well as Quality of Life in Patients With Low- to High-risk Cancer and H · not yet recruiting
- NCT07476365 — A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07056738 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Center Goettingen
- Last refreshed: 9 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07056738.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing